Phase 2 Rare Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are 18 years of age or older (or considered a legal adult)
• You have been formally diagnosed with advanced or spreading non-small cell lung cancer (NSCLC) that has specific gene mutations called EGFR or HER2 mutations in certain parts of the gene
• You have already received standard treatments for your condition
• You have at least one measurable area of cancer outside the brain that can be tracked during the trial
• Your overall health and ability to carry out daily activities meets a certain minimum level (confirm with trial site)
• You are expected to live for at least 3 months or more
• Your blood, liver, and kidney functions are at acceptable levels (confirm with trial site)

Who may not be able to join:

• You have been diagnosed with another cancer in the past 2 years
• Your cancer has other specific gene changes (such as certain MET gene amplifications) or has changed into a different type of cancer (such as small cell lung cancer)
• You still have unresolved side effects from previous cancer treatments
• You have a significant medical condition that is not well controlled, such as an active infection
• You have a history of a lung condition called interstitial lung disease, caused by any reason
• You have had a serious heart or blood vessel event in the past 6 months, or have a significant history of major organ problems (confirm with trial site)
• You are currently taking part in another clinical trial and receiving an experimental treatment

Important: Always verify eligibility with the trial site directly before applying.